Table 5 Effects of FSC-S and FSC-SpEt supplementation on stomach and residual gastric content and fecal TC excretion in normal and experimental hypercholesterolemic (HCL) mice

Normal mice

ND

–

0.34 ± 0.02

1.18 ± 0.06

1.26 ± 0.06

0.55 ± 0.06

1.92 ± 0.20

2.05 ± 0.21

5.91 ± 0.22

ND/FSC-S

9

0.25 ± 0.02^**

1.25 ± 0.06

1.38 ± 0.07

0.73 ± 0.06^*

3.59 ± 0.20^**

3.97 ± 0.23^**

5.21 ± 0.57

ND/FSC-SpEt

9

0.32 ± 0.01

1.12 ± 0.03

1.20 ± 0.03

0.45 ± 0.05

1.59 ± 0.19

1.70 ± 0.20

4.82 ± 0.29^**

ND/FF

0.05

0.28 ± 0.02^*

1.02 ± 0.05^*

1.31 ± 0.06

0.42 ± 0.03

1.53 ± 0.10

1.70 ± 0.11

6.72 ± 0.40

HCL mice

ND

–

0.31 ± 0.01

1.06 ± 0.03

1.13 ± 0.03

0.61 ± 0.09

2.06 ± 0.26

2.20 ± 0.28

5.24 ± 0.47

HCBD

–

0.30 ± 0.01

1.05 ± 0.03

1.12 ± 0.03

0.53 ± 0.06

1.82 ± 0.20

1.96 ± 0.22

23.18 ± 1.00^**

HCBD/FSC-S

3

0.29 ± 0.01

0.99 ± 0.04

1.08 ± 0.04

0.49 ± 0.09

1.70 ± 0.32

1.88 ± 0.37

23.72 ± 0.80

9

0.28 ± 0.01

1.12 ± 0.04

1.26 ± 0.04^#

0.66 ± 0.08

2.57 ± 0.27^#

2.91 ± 0.31^#

20.86 ± 1.06

HCBD/FSC-SpEt

3

0.31 ± 0.02

1.08 ± 0.06

1.16 ± 0.06

0.36 ± 0.02^#

1.27 ± 0.07^#

1.37 ± 0.08^#

25.43 ± 1.72

9

0.30 ± 0.01

1.07 ± 0.04

1.15 ± 0.04

0.41 ± 0.04^#

1.41 ± 0.12

1.53 ± 0.13

24.87 ± 0.96

HCBD/FF

0.05

0.31 ± 0.01

1.10 ± 0.04

1.25 ± 0.04^#

0.37 ± 0.04^#

1.29 ± 0.11^#

1.47 ± 0.12

27.84 ± 1.19^##